✦ LIBER ✦

Clinical outcome of patients with follicular lymphoma and bulky disease after Rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy

✍ Scribed by Fabienne McClanahan; Thomas Hielscher; Michael Rieger; Manfred Hensel; Kai Neben; Jens Hillengass; Klaus Herfarth; Anthony D. Ho; Mathias Witzens-Harig

Book ID: 114794770
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 190 KB
Volume: 85
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2010.01445.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Clinical Outcomes After PC

Comparison of Clinical Outcomes After PCI With DES in Diabetic Patient with and Without Microvascular Disease

✍ Takama, Takuro 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Vitamin D Deficiency Impairs Rituximab-M

Vitamin D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With but Not Without Rituximab

✍ Bittenbring, J. T.; Neumann, F.; Altmann, B.; Achenbach, M.; Reichrath, J.; Ziep 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 442 KB

Bulky disease is an adverse prognostic f

Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma

✍ Richard B. Wilder; Maria A. Rodriguez; Chul S. Ha; Barbara Pro; Mark A. Hess; Fe 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB